UnSpun

Share this post

Bayer facing long line-up of new Roundup trials as cancer takes toll

careygillam.substack.com

Discover more from UnSpun

Getting behind the spin and shining a light on risks to our environment and our health.
Over 1,000 subscribers
Continue reading
Sign in

Bayer facing long line-up of new Roundup trials as cancer takes toll

30,000 still pursuing claims

carey gillam
Aug 23, 2022
5
Share this post

Bayer facing long line-up of new Roundup trials as cancer takes toll

careygillam.substack.com
6
Share

(Mike Langford at home. Photo by Dan Williams)

Cancer has taken an unrelenting toll on 72-year-old Mike Langford. After being diagnosed with non-Hodgkin lymphoma (NHL) in 2007 he suffered through five recurrences despite multiple rounds of chemotherapy and a stem cell transplant. Now he struggles with chemo-related neuropathy in his arms and legs, and new tests show the cancer is back.

Langford blames his cancer on his longtime use of the popular weed-killing product Roundup, which he applied countless times over decades using a backpack sprayer around his five-acre California property and a vacation lake home. He alleges in a lawsuit that Monsanto, the longtime Roundup maker now owned by the German company Bayer AG, should have warned of a cancer risk.

Last month, a San Francisco judge ruled that Langford’s health is so poor that he is entitled to a speedy hearing of his claims. A trial is set for Nov. 7 in San Francisco County Superior Court.

“I’ve had it so long. I’m very angry,” Langford said in an interview, a day after doctors biopsied an enlarged lymph node. “The future doesn’t look too terribly promising,” he said, trying to hold back tears. He learned last week that the preliminary biopsy results show a return of NHL.

Langford’s is just one of a long list of upcoming trials complicating Bayer’s efforts to escape the costly, ongoing litigation over the health effects of Roundup. As part of the sweeping, nationwide legal battle that has so far run seven years, approximately 140,000 plaintiffs have alleged they developed NHL from exposure to Roundup, and should have been warned of the risk.

One trial is underway now in Monsanto’s former hometown of St. Louis, Missouri, while another in Missouri is scheduled to start in October and yet another trial is set in Hawaii for November. Several others are on court calendars in Arizona, Arkansas, California, Florida and elsewhere well into 2023.

For plaintiffs lawyers, the new trials mark a renewed effort to either force Roundup off the market or ensure a cancer warning is added to the weedkiller’s label. For Bayer, they mark a chance to add to its current Roundup trial record of 4 wins and 3 losses.

This story is co-published with The Guardian.

Read the rest of the story

Share

Donate

5
Share this post

Bayer facing long line-up of new Roundup trials as cancer takes toll

careygillam.substack.com
6
Share
6 Comments
Share this discussion

Bayer facing long line-up of new Roundup trials as cancer takes toll

careygillam.substack.com
James Sherwood Seaton
Aug 23, 2022Liked by carey gillam

Thank you for keeping us informed.

Expand full comment
Reply
Share
Gail Peterson
Aug 24, 2022Liked by carey gillam

All of us who follow Carey, we need an address (and all of us should take the time and write a real letter, that's post marked by the Post Office. If they get hit by a barrage of mail, hopefully it will calls someone's attention. Yes they are the big guys, but we are suffering as a result of their greed and games. I understand this has a tendency to hit older people, it takes time to manifest. But our Bees get slaughtered by the spraying of this hideous Chemical, which destroys our food supply. So it not only for the older, but those who want to live to become older!!! Moms all around the country need to join in on this battle!!!!

Expand full comment
Reply
Share
4 more comments...
Top
New
Community

No posts

Ready for more?

© 2023 carey gillam
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing